FRAIDA STREITER: Open Payments
NPI 1154099539 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 70 payments from 6 companies in 2025. Trend: 2023 $1,939 · 2024 $2,080 · 2025 $1,442
Food & beverage: $1,442
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 29 | $501 |
| Neos Therapeutics, LP | 13 | $281 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $271 |
| Axsome Therapeutics, Inc. | 9 | $209 |
| Tris Pharma Inc | 8 | $157 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: REXULTI, TRINTELLIX, Adzenys XR-ODT, Auvelity, Dyanavel XR, EXXUA, CAPLYTA, Onyda XR.
Industry payments across NY — which companies pay providers there.
